Aureus Asset Management, LLC Incyte Corp Transaction History

Aureus Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $222,540 - $326,790	-3,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $190,680 - $264,510	3,000 New	3,000 $258,000
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $263,250 - $314,730	-4,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $92,625 - $111,345	1,500 Added 50.0%	4,500 $311,000
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $249,180 - $302,940	3,000 New	3,000 $250,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aureus Asset Management, LLC with notifications on news.